GX 623 (Ziagen 300 mg)

Generic Name: abacavir

Pill imprint GX 623 has been identified as Ziagen 300 mg.

Ziagen is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Ziagen 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for GX 623 (Ziagen 300 mg)

Ziagen 300 mg GX 623
Ziagen 300 mg GX 623
Ziagen 300 mg GX 623
Ziagen
Generic Name:
abacavir
Imprint:
GX 623
Strength:
300 mg
Color:
Yellow
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline
National Drug Code (NDC):
00173-0661
Inactive Ingredients:
silicon dioxide colloidal
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromelloses
polysorbate 80
ferric oxide yellow
triacetin
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
49702-0221 ViiV Healthcare
54569-4883 A S Medication Solutions LLC (repackager)
54868-4522 Physicians Total Care Inc (repackager)
35356-0075 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)